SAM
IPXL

Solaris Asset Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Solaris Asset Management’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-925
Closed -$12K – 292
2016
Q4 		$12K Buy
925
+767
+485% +$13.1K 0.01% 217
2016
Q3 		$4K Buy
+158
New +$4.25K ﹤0.01% 447

Other funds holding IPXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Solaris Asset Management's IPXL Position: Q1 2017 in Review

Solaris Asset Management sold out of Impax Laboratories, Inc. (IPXL) in Q1 2017, closing a stake of 925 shares — an estimated $12K sold.

Solaris Asset Management first reported a position in IPXL in Q3 2016 and held it in 2 quarters. The position peaked at $12K in Q4 2016. 178 funds tracked by Wall St. Rank hold IPXL as of Q1 2017.

  • Solaris Asset Management reported no remaining Impax Laboratories, Inc. position as of Q1 2017 after selling out during the quarter.
  • Solaris Asset Management sold 925 Impax Laboratories, Inc. shares in Q1 2017, an estimated $12K.
  • Solaris Asset Management first reported a position in Impax Laboratories, Inc. in Q3 2016 and held it in 2 quarters.
  • Solaris Asset Management's Impax Laboratories, Inc. position peaked at $12K in Q4 2016.
  • 178 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2017.

Based on Solaris Asset Management's 13F filing for Q1 2017, filed 3 May 2017.